Featured Articles

RGC Resources Offers 7% Quarterly Dividend Boost (RGCO)
Ned Piplovic | January 4, 2018
Over the past two decades, RGC Resources, Inc. (NASDAQ:RGCO) failed to hike its annual dividend only once and has boosted its quarterly distribution almost 7%, which makes 2018 the 14th consecutive year that the company has augmented its annual payout. The current dividend yield fell to just 2.25% because of the rapid share-price growth in the last year. Over the…

Term Trust Closed-End Fund Added to Portfolio
Tim McPartland | January 3, 2018
By Tim McPartland While we are always skeptical of owning closed-end funds (CEFs), we do on occasion stumble upon one that fits our needs in almost all respects. Meeting our needs means that the share price appears to have limited downside, the issue has a satisfactory current yield and the security has a relatively short duration to maturity. Very few…

City Holding Company Hiked its Quarterly Dividend 4.5%, Pays 2.7% Yield (CHCO)
Ned Piplovic | January 1, 2018
The City Holding Company currently pays a 2.7% yield and it hiked its current dividend payout 4.5% to mark the company’s seventh consecutive annual dividend boost. In addition to enhancing its annual dividend payout over the past seven consecutive years, the company raised its annual dividends 14 out of the last 16 years with no dividend cuts. City Holding’s share…

Norwood Financial Corporation Boosts Annual Dividend for Two Decades (NWFL)
Ned Piplovic | January 1, 2018
Norwood Financial Corporation (NASDAQ:NWFL) has hiked its annual dividend distribution every year since it started paying dividends in 1998 and currently offers its investors a 2.6% dividend yield. In addition to raising its annual dividend payout amount for 20 years, the company’s current yield is significantly higher than the average yield of all the other regional banks in the U.S.…

AbbVie Offers 2.9% Dividend Yield, 40%-Plus Above Peer Average (ABBV)
Ned Piplovic | December 31, 2017
AbbVie, Inc. currently offers its shareholders a 2.9% dividend yield, which exceeds the average yield of the company’s drug manufacturing peers by more than 40%. In addition to the better-than-average yield, the company has enhanced its annual dividend payout every year since 2013. Over the past year, the company grew its share price significantly, which combined with the rising dividend…


